Allergan also presented new insights on the growing population of patients on GLP-1 agonists for weight loss who are seeking aesthetic treatments
The presentations underscore the company’s deep expertise in dermatology and immunology
Since launching, the hospital has performed over 40 intestinal transplants, including 21 in 2025 alone
The Cambridge hub is designed to expand Zealand Pharma’s global research capabilities
The Institute of Human Biology (IHB) enables scientists to pioneer human model systems, accelerating the development of new medicines to improve the lives of patients
The global, first-in-human, open-label trial will assess the safety, tolerability, pharmacokinetics, and preliminary anti-tumor activity of TRI-611
The patent protects antiviral compounds developed by the company that inhibit Vacuolar ATPase (V-ATPase) activity in cells, a mechanism involved in viral infection pathways
The move opens Japan’s advanced life science market to Epigenica’s high-throughput epigenetic profiling kits
The planned facility, to be built at Samsung’s Bio Campus II, is set to become a launchpad for up to 30 emerging biotech firms
Subscribe To Our Newsletter & Stay Updated
